{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T07:17:25Z","timestamp":1785655045974,"version":"3.56.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.bbmt.2017.07.021","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T16:20:26Z","timestamp":1500999626000},"page":"1817-1825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment"],"prefix":"10.1016","volume":"23","author":[{"given":"Rajinder P.S.","family":"Bajwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris M.","family":"Mahadeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Taragin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asumthia","family":"Jeyapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tamburro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Gehred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery J.","family":"Auletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Woolfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.07.021_bib0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00043426-200212000-00013","article-title":"Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients","volume":"24","author":"Reiss","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","article-title":"Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients","volume":"32","author":"Barker","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0020","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0025","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bmt.2009.349","article-title":"Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: Incidence, risk factors, and outcome","volume":"45","author":"Lee","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbmt.2014.09.026","article-title":"Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation","volume":"21","author":"Myers","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/bmt.2015.208","article-title":"Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children","volume":"51","author":"Naples","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0050","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bbmt.2016.07.011","article-title":"High variability in the reported management of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"22","author":"Skeens","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0055","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbmt.2008.08.008","article-title":"Variation in supportive care practices in hematopoietic cell transplantation","volume":"14","author":"Lee","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.hemonc.2013.04.001","article-title":"Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey","volume":"6","author":"Rasheed","year":"2013","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2648.2006.03716.x","article-title":"Consulting the oracle: ten lessons from using the Delphi technique in nursing research","volume":"53","author":"Keeney","year":"2006","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0075","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V67.6.1773.1773","article-title":"Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy","volume":"67","author":"Rio","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0085","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.bmt.1701464","article-title":"Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation","volume":"22","author":"Gordon","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0090","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbmt.2010.02.016","article-title":"Prediction of veno-occlusive disease using biomarkers of endothelial injury","volume":"16","author":"Cutler","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0095","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","article-title":"Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation","volume":"89","author":"Salat","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0100","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2141.2002.03748.x","article-title":"Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide","volume":"118","author":"Lee","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0105","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/pbc.23213","article-title":"Contribution of fibrinolytic tests to the differential diagnosis of veno-occlusive disease complicating pediatric hematopoietic stem cell transplantation","volume":"58","author":"Sartori","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1703544","article-title":"Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/pbc.22314","article-title":"Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation","volume":"54","author":"Iguchi","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","article-title":"Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study","volume":"22","author":"Lee","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0125","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00432-014-1857-2","article-title":"Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"141","author":"Seifert","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0130","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.bbmt.2015.07.004","article-title":"Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation","volume":"21","author":"Akil","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiology.204.2.9240551","article-title":"Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients","volume":"204","author":"Lassau","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002470000373","article-title":"Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings","volume":"31","author":"McCarville","year":"2001","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00007890-200207150-00011","article-title":"Prognostic value of Doppler-ultrasonography in hepatic veno-occlusive disease","volume":"74","author":"Lassau","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0150","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1148\/radiol.10100025","article-title":"Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation","volume":"258","author":"Mahgerefteh","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jvir.2016.01.007","article-title":"Assessing the risk of hemorrhagic complication following transjugular liver biopsy in bone marrow transplantation recipients","volume":"27","author":"Ahmed","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jvir.2012.09.011","article-title":"Safety and utility of transjugular liver biopsy in hematopoietic stem cell transplant recipients","volume":"24","author":"Kis","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0165","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jvir.2012.02.012","article-title":"Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions","volume":"23","author":"Patel","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1034\/j.1600-0676.2001.210105.x","article-title":"Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation\u2013role of transjugular intrahepatic portosystemic shunt (TIPS)","volume":"21","author":"Zenz","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0175","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00007890-199504150-00017","article-title":"Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients","volume":"59","author":"Shulman","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0180","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/MPH.0b013e3182025236","article-title":"Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation","volume":"33","author":"Oshrine","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0185","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/gut.24.11.1057","article-title":"Experience with transjugular liver biopsy","volume":"24","author":"Bull","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0195","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-0012.2012.01604.x","article-title":"Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review","volume":"26","author":"Zhang","year":"2012","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.bbmt.2017.07.021_bib0205","article-title":"Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation","author":"Cheuk","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0215","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/ehm.12.18","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"5","author":"Corbacioglu","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"Dignan","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0245","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pbc.21425","article-title":"Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children","volume":"50","author":"Qureshi","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0250","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation","volume":"47","author":"Marsa-Vila","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0255","first-page":"414a","article-title":"Low molecular weight heparin in prophylaxis of venoocclusive disease in patients undergoing bone marrow transplantation","volume":"88","author":"Lee","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1705724","article-title":"Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels","volume":"40","author":"Matsumoto","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0265","first-page":"S198","article-title":"Intravenous versus oral busulfan administration results into a dramatic reduction of veno-occlusive disease (VOD) incidence in a randomised trial assessing fresh frozen plasma+heparin versus heparin-alone as anti-VOD prophylaxis","volume":"47","author":"Yannaki","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0270","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.1769.1769","article-title":"A randomized trial of heparin plus anti-thrombin III (ATIII) vs. heparin alone to prevent VOD after HSCT","volume":"106","author":"Jung","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0275","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy","volume":"91","author":"Haussmann","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0280","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3346\/jkms.2006.21.5.897","article-title":"Prophylactic low-dose heparin or prostaglandin E may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children","volume":"21","author":"Song","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0285","first-page":"620a","article-title":"Prevention of veno-occlusive disease (VOD) of the liver after marrow and blood progenitor cell transplantation: a prospective randomised study of different prophylactic regimens","volume":"86","author":"Demuynck","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0290","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation","volume":"11","author":"Bearman","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9343(80)90368-X","article-title":"Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation","volume":"68","author":"Woods","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0300","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0305","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0310","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/bmt.2009.56","article-title":"Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome","volume":"44","author":"Sakai","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0320","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0405","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0325","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2014-03-551630","article-title":"How I treat sinusoidal obstruction syndrome","volume":"123","author":"Chao","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0330","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s002470000373","article-title":"Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings","volume":"31","author":"McCarville","year":"2001","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0335","first-page":"1122","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European Compassionate-Use Study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0345","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.20934","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease in children","volume":"48","author":"Bulley","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0350","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0355","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide\u2014compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0360","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multi-organ failure post stem cell transplantation: a multi-center, randomized, dose finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0365","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0370","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0375","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0380","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","article-title":"Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients","volume":"89","author":"Bearman","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0385","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bmt.1703881","article-title":"Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment","volume":"31","author":"Bajwa","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0390","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bmt.1705896","article-title":"Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone","volume":"41","author":"Al Beihany","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0395","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbmt.2012.11.011","article-title":"High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients","volume":"19","author":"Myers","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.07.021_bib0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s002770050358","article-title":"Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin","volume":"76","author":"Schlegel","year":"1998","journal-title":"Ann Hematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117306122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117306122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:14Z","timestamp":1761058754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117306122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1083879117306122"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.021","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}